The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer

Journal of Nuclear Medicine

Volumn 47, Issue 11, 2006, Pages 1756-1762

  Gayed, Isis W ^a   Liu, H Helen ^a   Yusuf, Syed Wamique ^a   Komaki, Ritusko ^a   Wei, Xiong ^a   Wang, Xuanmin ^a   Chang, Joe Y ^a   Swafford, Joseph ^a   Broemeling, Lyle ^a   Liao, Zhongxing ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Esophageal cancer; Gated myocardial perfusion imaging; Myocardial ischemia; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ESOPHAGUS CANCER; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SURVIVAL RATE; SURVIVAL TIME; CHEMICALLY INDUCED DISORDER; DRUG THERAPY; ESOPHAGUS TUMOR; HEART MUSCLE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PERFUSION; PREVALENCE; RADIOTHERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL MODEL;

AGED; DRUG THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PERFUSION; PREVALENCE; RADIATION INJURIES; RADIOTHERAPY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34547416155     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Devesa S, Fraumeni J. The rising incidence of gastric cardia cancer. J Natl Cancer Inst. 1999;91:747-749.
2. Prosnitz RG, Chen YH, Marks LB. Cardiac toxicity following thoracic radiation. Semin Oncol. 2005;32:S71-S80.
3. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet. 2000;355:1757-1770.
4. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12:447-452.
5. Rutqvist LE, Lax I, Fornando T, et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992;22:887-896.
6. Boivin JF, Hutchinson GB, Lubin JH, et al. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 1992;69:1241-1247.
7. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA. 1993;270:1949-1955.
8. Lee PJ, Mallik R. Cardiovascular effects of radiation therapy: practical approach to radiation therapy-induced heart disease. Cardiol Rev. 2005;13:80-86.
9. Liu HH, Wang X, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1268-1279.
10. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:1336-1344.
11. Bush DA, Slater JD, Shin BB, et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest. 2004;126:1198-1203.
12. Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys. 2005;62:554-560.
13. Cooper S, Spiro SG. Small cell lung cancer: treatment review. Respirology. 2006;11:241-248.
14. Mantovani C, Novello S, Ragona R, et al. Chemo-radiotherapy in lung cancer: state of the art with focus on the elderly population. Ann Oncol. 2006;17(suppl 2):61-63.
15. Prosnitz RG, Marks LB. Radiation-induced heart disease: vigilance is still required. J Clin Oncol. 2005;23:7391-7394.
16. Mantini G, Smaniotto D, Balducci M, et al. Radiation-induced cardiovascular disease: impact of dose and volume. Rays. 2005;30:157-168.
17. Chen MH, Cash EP, Danias PG, et al. Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer. J Cardiovasc Magn Reson. 2002;4:265-271.
18. Remouchamps VM, Vicini FA, Sharpe MB, et al. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys. 2003;55:392-406.
19. Landau D, Adams EJ, Webb S, et al. Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol. 2001;60:247-255.
20. Goethals I, De Winter O, De Bondt P, et al. The clinical value of nuclear medicine in the assessment of irradiation-induced and anthracycline-associated cardiac damage. Ann Oncol. 2002;13:1331-1339.
21. Gyenes G, Fornander T, Carlens P, et al. Detection of radiation induced myocardial damage by technetium-99m sestamibi scintigraphy. Eur J Nucl Med. 1997;24:286-292.
22. Gyenes G, Fornander T, Carlens P, et al. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys. 1996;36:899-905.
23. Hardenbergh PH, Munely MT, Bentel GC, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys. 2001;49:1023-1028.
24. Marks LB, Yu X, Prosnitz RG, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005;63:214-223.
25. Tripp P, Malhotra K, Javle M, et al. Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changes. Dis Esophagus. 2005;18:400-405.
26. Gyenes G, Fornander T, Carlens P, et al. Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy. Eur J Nucl Med. 1997;24:286-292.
27. Brosius FC III, Waller BF, Roberts WC. Radiation heart disease: analysis of 16 young (aged 15-33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med. 1981;70:519-530.
28. Orzan F, Brusca A, Conte MR, et al. Severe coronary artery disease after radiation therapy of chest and mediastinum: clinical presentation and treatment. Br Heart J. 1993;69:496-500.
29. Girinsky T, Pichento C, Beaudre A, et al. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes? Int J Radiat Oncol Biol Phys. 2006;64:218-226.